Juan Jesús
Cruz Hernández
Profesor Emérito
Hospital Universitario La Fe
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (8)
2018
-
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)
British Journal of Cancer, Vol. 119, Núm. 9, pp. 1052-1059
-
SEOM clinical guidelines for the treatment of head and neck cancer (2017)
Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 75-83
2017
-
Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study
International Journal of Radiation Oncology Biology Physics, Vol. 97, Núm. 3, pp. 473-480
-
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: A multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)
Annals of Oncology, Vol. 28, Núm. 12, pp. 2994-2999
-
Manejo de la infección y la neutropenia febril en el paciente con cáncer sólido
Enfermedades Infecciosas y Microbiologia Clinica
2016
-
Management of infection and febrile neutropenia in patients with solid cancer
Clinical and Translational Oncology, Vol. 18, Núm. 6, pp. 557-570
2005
-
Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5- fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study
European Journal of Cancer, Vol. 41, Núm. 9, pp. 1254-1260
2002
-
Estudio de la astenia tumoral: Constituci-acon del grupo ASTHENOS
Revista Clinica Espanola, Vol. 202, Núm. 10, pp. 525-528